메뉴 건너뛰기




Volumn 125, Issue 2, 2012, Pages 409-413

Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosis

Author keywords

Cytoreduction; Metastasis; Outcome; Surgery; Uterine leiomyosarcoma

Indexed keywords

DOCETAXEL; DOXORUBICIN; GEMCITABINE;

EID: 84859580563     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.02.014     Document Type: Article
Times cited : (54)

References (12)
  • 2
    • 65349159791 scopus 로고    scopus 로고
    • Stage-specific outcomes of patients with uterine leiomyosarcoma: A comparison of the International federation of Gynecology and Obstetrics and American Joint Committee on Cancer Staging Systems
    • Zivanovic O, Leitao MM, Iasonos A, Jacks LM, Zhou Q, Abu-Rustum NR, et al. Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the International federation of Gynecology and Obstetrics and American Joint Committee on Cancer Staging Systems. J Clin Oncol 2009;27:2066-72.
    • (2009) J Clin Oncol , vol.27 , pp. 2066-2072
    • Zivanovic, O.1    Leitao, M.M.2    Iasonos, A.3    Jacks, L.M.4    Zhou, Q.5    Abu-Rustum, N.R.6
  • 3
    • 0030220213 scopus 로고    scopus 로고
    • Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: A Gynecologic Oncology Group study
    • DOI 10.1006/gyno.1996.0220
    • Sutton G, Blessing JA, Malfetano JH. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group Study. Gynecol Oncol 1996;62:226-9. (Pubitemid 26274804)
    • (1996) Gynecologic Oncology , vol.62 , Issue.2 , pp. 226-229
    • Sutton, G.1    Blessing, J.A.2    Malfetano, J.H.3
  • 4
    • 44449096592 scopus 로고    scopus 로고
    • Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II trial
    • DOI 10.1016/j.ygyno.2008.03.010, PII S0090825808002047
    • Hensley ML, Blessing JA, Mannel R, Rose PG. Fixed-dose rate gemcitabine plus doetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial. Gynecol Oncol 2008;109:329-34. (Pubitemid 351754961)
    • (2008) Gynecologic Oncology , vol.109 , Issue.3 , pp. 329-334
    • Hensley, M.L.1    Blessing, J.A.2    Mannel, R.3    Rose, P.G.4
  • 5
    • 67349224121 scopus 로고    scopus 로고
    • Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgica paradigm
    • Chi DS, Eisenhauer EL, Zivanovic O, Sonoda Y, Abu-Rusutm NR, Levine DA, et al. Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgica paradigm. Gynecol Oncol 2009;114:26-31.
    • (2009) Gynecol Oncol , vol.114 , pp. 26-31
    • Chi, D.S.1    Eisenhauer, E.L.2    Zivanovic, O.3    Sonoda, Y.4    Abu-Rusutm, N.R.5    Levine, D.A.6
  • 8
    • 34250186054 scopus 로고    scopus 로고
    • Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma
    • DOI 10.1016/j.ygyno.2007.02.031, PII S0090825807001801
    • Giuntoli II RL, Garett-Mayer E, Bristow RE, Gostout BS. Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma. Gynecol Oncol 2007;106: 82-8. (Pubitemid 46901078)
    • (2007) Gynecologic Oncology , vol.106 , Issue.1 , pp. 82-88
    • Giuntoli II, R.L.1    Garrett-Mayer, E.2    Bristow, R.E.3    Gostout, B.S.4
  • 9
    • 41549166181 scopus 로고    scopus 로고
    • Uterine mesenchymal tumors: A review of selected topics
    • DOI 10.1016/j.mpdhp.2008.02.009, PII S1756231708000339
    • Soslow RA. Uterine mesenchymal tumors: a review of selected topics. Diagn Histopathol 2008;14:175-88. (Pubitemid 351470160)
    • (2008) Diagnostic Histopathology , vol.14 , Issue.4 , pp. 175-188
    • Soslow, R.A.1
  • 11
    • 78651372008 scopus 로고    scopus 로고
    • Systematic review on the efficacy of multimodal treatment of sarcomatosis with cytoreduction and intraperitoneal chemotherapy
    • Munene G, Mack LA, Temple WJ. Systematic review on the efficacy of multimodal treatment of sarcomatosis with cytoreduction and intraperitoneal chemotherapy. Ann Surg Oncol 2011;18:207-13.
    • (2011) Ann Surg Oncol , vol.18 , pp. 207-213
    • Munene, G.1    Mack, L.A.2    Temple, W.J.3
  • 12
    • 0036498788 scopus 로고    scopus 로고
    • Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis
    • DOI 10.1200/JCO.20.5.1248
    • Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002;20:1248-59. (Pubitemid 34177431)
    • (2002) Journal of Clinical Oncology , vol.20 , Issue.5 , pp. 1248-1259
    • Bristow, R.E.1    Tomacruz, R.S.2    Armstrong, D.K.3    Trimble, E.L.4    Montz, F.J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.